EU Policy on Lung Cancer CT Screening 2017.

Area of Science:

• Oncology
• Public Health Policy

Background:

• Lung cancer is a leading cause of cancer death in Europe, with 269,000 deaths in the EU-28 in 2013.
• Low-dose computed tomography (LDCT) screening can detect lung cancer early, improving patient outcomes.
• LDCT screening trials show high rates of early-stage detection (around 70%) and excellent survival rates (88% 10-year survival for screen-detected cancers).

Purpose of the Study:

• To recommend the establishment of an EU Commission expert group for lung cancer CT screening.
• To support the development of policy and recommendations for lung cancer CT screening implementation.
• To advise on the monitoring, evaluation, and dissemination of screening program results.

Main Methods:

• Establish an EU Commission expert group under Article 168(2) of the Treaty on the Functioning of the European Union.
• The expert group will assist in drafting policy documents, guidelines, and recommendations.
• The group will advise on implementing screening actions and suggest improvements.

Main Results:

• An EU Expert Group on lung cancer screening should be established by the EU Commission.
• The group is recommended to support implementation and provide recommendations by 2019/2020.
• This expert group will facilitate a coordinated approach to lung cancer screening policy.

Conclusions:

• A well-organized lung cancer CT screening program is essential for reducing lung cancer mortality in Europe.
• The proposed expert group will play a crucial role in achieving this goal.
• Early detection through screening can significantly improve patient survival rates.